Navigation Links
Lithotripters Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
Date:7/7/2011

NEW YORK, July 7, 2011 /PRNewswire/ --

Reportlinker.com announces that a new market research report is available in its catalogue:

Lithotripters Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

http://www.reportlinker.com/p0567528/Lithotripters-Market-Outlook-in-BRICS-Brazil-Russia-India-China-South-Africa-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Devices

Lithotripters Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Summary

GlobalData's new report, "Lithotripters Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017" provides key market data on the Lithotripters market in the BRICS countries. The report provides value (USD million), volume (units) and average price (USD) data for each segment within two market categories – Extracorporeal Shock Wave Lithotripters and Laser Lithotripters. The report also provides company shares and distribution shares data for the overall Lithotripters market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

The emerging economies, comprising of China, India, Brazil, Russia, and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world's most populous country and is consequently home to a large patient base. The country is home t
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
2. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
3. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
4. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
5. Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday, November 1, 2007
6. Inverness Medical Innovations to Present at CIBC World Markets 18th Annual Healthcare Conference on November 7, 2007
7. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
8. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
9. Replidyne to Participate on Anti-infective Panel at RBC Capital Markets Healthcare Conference
10. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
11. Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013  Cephasonics, a technology-innovation ... announced the introduction of the cQuest Ultrasound ... communications with all cQuest Ultrasound™ hardware platforms. ... including this new capability, at Hospitalar 2013 ... from May 21-24.  Cephasonics is ...
(Date:5/21/2013)... , May 21, 2013 Hurel Corporation ("Hurel"), ... microfluidic cell-based assay platforms, today announced the appointment of ... to the Company,s Board of Directors. Dr. MacDonald is ... the Schering-Plough Research Institute ("SPRI"), which was the pharmaceutical ... by Merck & Co. in 2009. Over ...
(Date:5/21/2013)... N.Y. , May 21, 2013  Vasomedical, Inc. (OTC ... in the design, manufacture and sale of medical devices and ... that Dr. Jun Ma , President and ... Marcum LLP MicroCap Conference on Thursday, May 30, 2013 in ... Hyatt Hotel. The Company,s presentation is scheduled ...
Breaking Medicine Technology:Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2
... improvement solutions provider GP Strategies Corporation (NYSE: ... ended March 31, 2012. Overview of First Quarter ... quarter of 2012 compared to $64.3 million for first quarter of ... of 2012 compared to $4.3 million for first quarter of 2011 ...
... 2012 Valeant Pharmaceuticals International, Inc. (NYSE: ... that Valeant has agreed to acquire certain assets ... company focused on skincare products, for approximately $64 ... future revenue targets.  University Medical,s main brand is ...
Cached Medicine Technology:GP Strategies Reports Strong First Quarter 2012 EPS of $0.23 2GP Strategies Reports Strong First Quarter 2012 EPS of $0.23 3GP Strategies Reports Strong First Quarter 2012 EPS of $0.23 4GP Strategies Reports Strong First Quarter 2012 EPS of $0.23 5GP Strategies Reports Strong First Quarter 2012 EPS of $0.23 6Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical 2
(Date:5/21/2013)... Boca Raton, Fla. (PRWEB) May 21, 2013 ... TV program distributed on cable networks and cable channels ... of new episodes on its YouTube channel. The producers ... profiles of companies in the shipping industry, the manufacturing ... program highlights pioneering medical facilities and medical practitioners in ...
(Date:5/21/2013)... MedMar Healing Center announces their participation in ... Bank. Twenty-eight businesses, including MedMar Healing Center, doctors, and clubs, ... goal is to raise food to help area kids who ... in recent years. , “We like being able to ... explains Douglas Chloupek of MedMar Healing Center. “Taking part in ...
(Date:5/21/2013)... (May 21, 2013) Research into genetic features of ... of Colorado School of Medicine may lead to improved ... paper published online by JAMA . , The ... survival in some cases of pulmonary fibrosis, a chronic ... As a result of the study, researchers may want ...
(Date:5/21/2013)... 2013 The nation’s first trial involving ... nearing its conclusion in Washington state court, Bernstein Liebhard ... yesterday, an attorney for the Plaintiffs compared Intuitive Surgical ... tie sales and services for its customers. ... control of surgeons, to keep control of hospitals and ...
(Date:5/21/2013)... May 21, 2013 Two executives from ... (SBG) will identify which strategies can be most effective ... care to the members who are taking them, in ... Inc., “How to Manage Specialty Drugs to Reduce ... are now the main driver for rising prescription drug ...
Breaking Medicine News(10 mins):Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2Health News:San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank 2Health News:Researchers find genetic tie to improved survival time for pulmonary fibrosis 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4Health News:Consulting Firm Execs to Discuss Strategies for Effective Management of Specialty Drugs in AIS’s May 30 Webinar 2
... MONICA, Calif., Dec. 7 California,s,stem cell agency ... it was,rejecting 10 applications for research grants because ... billion stem cell program, the,Foundation for Taxpayer and ... consumer advocacy organization added that,to completely resolve the ...
... Dec. 7 Legendary blues artists Bobby,Rush and James ... the inaugural Mississippi Blues Marathon and Half-Marathon on Saturday,January ... & Mal,s, located at 200,South Commerce Street, in downtown ... scheduled to go on stage at 8:00 p.m., and ...
... for four blood proteins may provide a less-invasive follow-up for ... tomography (CT) scans, according to a new study led by ... a very high false positive rate when trying to discover ... Duke and lead investigator on the study. What that leads ...
... BioHorizons Implant Systems,Inc. relocated its global ... 44,000 square foot facility. The new facility, ... services, a newly,formed manufacturing facility and a ... surface treatment and packaging services., The ...
... 7 As of December 7,2007, Coshocton County Memorial ... nurses for a 3-year contract. As a result,bargaining unit ... strike,and maintain a picket line starting at 7:00 a.m. ... highly developed skills and extensive,education. Each and every day ...
... BAN(R)/Seventeen.com Stress Relief Survey are in, NEW YORK, Dec. ... and messy breakups anymore. The fast-paced world we live in ... people, especially young,women, face. This trend can be seen in ... what are some of the factors that contribute,to this new ...
Cached Medicine News:Health News:Stem Cell Institute Correct in Rejecting Applications Over Conflicts of Interest; Institutions, Board Members Involved Must Be Identified, Consumer Advocates Say 2Health News:Stem Cell Institute Correct in Rejecting Applications Over Conflicts of Interest; Institutions, Board Members Involved Must Be Identified, Consumer Advocates Say 3Health News:Study points to possibility of blood test to detect lung cancer 2Health News:BioHorizons Expands to New 44,000 Square Foot Facility 2Health News:Coshocton County Memorial Hospital RNs to Strike Despite Hospital's Claim of Financial Hardship 2Health News:Coshocton County Memorial Hospital RNs to Strike Despite Hospital's Claim of Financial Hardship 3Health News:What Stresses Teens Out 2Health News:What Stresses Teens Out 3
Liquichek Reticulocyte Control is a human whole blood based control designed to monitor manual and automated methods for counting reticulocytes. Assayed values are provided at three clinically signif...
Liquichek Hematology Control (C) is an assayed hematology control for evaluating the performance of Coulter hematology instruments with complete CBC and VCS 5-part differential technology....
... Liquichek Lipids Control is ... product that provides the ... analyte levels for lipids ... C-Reactive Protein in levels ...
... Control (Human) provides a comprehensive analyte ... and CO2. It requires no special ... major instruments and methodologies. Available in ... sizes (10 mL fill size available ...
Medicine Products: